Functional experiments proved that SATB2-AS1 dampened HCC cell proliferation and metastasis and expedited its apoptosis, thus inactivating the miR-3678-3p/GRIM-19/STAT3/HIF-1α pathway. Here, SATB2 is linked to hepatocellular carcinoma.